Novel Application of Capture-Recapture Methods to Estimate the Completeness of Contact Tracing During a Large Outbreak of Ebola Virus Disease, Democratic Republic of Congo, 2018-2020

Despite its critical role in containing outbreaks, the efficacy of contact tracing (CT), measured as the sensitivity of case detection, remains an elusive metric. We estimated the sensitivity of CT by applying unilist capture-recapture methods on data from the 2018-2020 outbreak of Ebola virus disea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of infectious diseases 2022-03, Vol.116, p.S98-S98
Hauptverfasser: Polonsky, J., Böhning, D., Keita, M., Ahuka-Mundeke, S., Nsio-Mbeta, J., Mossoko, M., Kaiser, L., Yoti, Z., Sangnawakij, P., Lerdsuwansri, R., Vilas, V. DelRio
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Despite its critical role in containing outbreaks, the efficacy of contact tracing (CT), measured as the sensitivity of case detection, remains an elusive metric. We estimated the sensitivity of CT by applying unilist capture-recapture methods on data from the 2018-2020 outbreak of Ebola virus disease in the Democratic Republic of Congo. We applied different distributional assumptions to the zero-truncated count data to estimate the number of unobserved cases with a) any contacts and b) infected contacts, to compute CT sensitivity. Geometric distributions were the best fitting models. Our results indicate that CT efforts identified almost all (n=792, 99%) of the cases with any contacts, but only half (n=207, 48%) of the cases with infected contacts, suggesting that CT efforts performed well at identifying contacts during the listing stage, but performed poorly during the contact follow-up stage. This novel approach can be applied to assess the effectiveness of CT. Importantly, the approach described is disease-agnostic, and can be extended to assess the sensitivity of CT for any disease, including COVID-19, for which CT has been identified as a crucial component of the response activities.
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2021.12.230